Our report further emphasizes the need for a comprehensive integrated approach to differentiate between nodal NMZL with a significant expansion of reactive PD1+ T-cells and primary PTCL-TFH [13,14,15,16,17,18,19,21]. This evidence concerns the gene PDCD1 and mature T-cell and NK-cell non-Hodgkin lymphoma.